Showing 201 - 220 results of 640 for search '(( significant fold decrease ) OR ( significant decrease decrease ))~', query time: 0.20s Refine Results
  1. 201

    S1 Data - by Perumal Vivekanandhan (4863484)

    Published 2024
    “…Additionally, 12 hours post-treatment, catalase (an antioxidant enzyme) activity decreased 1.5-fold in a dose-dependent manner, while glutathione S-transferase (a detoxification enzyme) activity increased 7.8-fold. …”
  2. 202
  3. 203
  4. 204
  5. 205
  6. 206
  7. 207

    Flow diagram of participants selection. by Wei Huang (36889)

    Published 2025
    “…Participants in the highest BRI quartile had 69-fold higher LMM odds versus the lowest quartile (OR=68.96, 95%CI = 33.62–141.47). …”
  8. 208

    Minimal data set. by Wei Huang (36889)

    Published 2025
    “…Participants in the highest BRI quartile had 69-fold higher LMM odds versus the lowest quartile (OR=68.96, 95%CI = 33.62–141.47). …”
  9. 209

    Weighted comparison of baseline characteristics. by Wei Huang (36889)

    Published 2025
    “…Participants in the highest BRI quartile had 69-fold higher LMM odds versus the lowest quartile (OR=68.96, 95%CI = 33.62–141.47). …”
  10. 210
  11. 211
  12. 212
  13. 213
  14. 214

    Histomorphometric analysis of the tumor volume fraction (V<sub>f</sub>) in the liver and necrosis volume fraction. by Bryan S. Margulies (21492667)

    Published 2025
    “…(B) Necrosis volume fraction was not significantly different between groups; however, there was a 3-fold decrease in necrosis for the 60-mg MBC-005 and a 2.25-fold decrease for the 120-mg MBC-005 treatment groups.…”
  15. 215
  16. 216

    Cox proportional hazard ratios. by Bryan S. Margulies (21492667)

    Published 2025
    “…Intratumoral administration of MBC-005 increased survival 3.9-fold in mice and significantly decreased tumor volume 4-fold. …”
  17. 217

    Bioluminescent Doubling Time. by Bryan S. Margulies (21492667)

    Published 2025
    “…Intratumoral administration of MBC-005 increased survival 3.9-fold in mice and significantly decreased tumor volume 4-fold. …”
  18. 218

    Study Design. by Bryan S. Margulies (21492667)

    Published 2025
    “…Intratumoral administration of MBC-005 increased survival 3.9-fold in mice and significantly decreased tumor volume 4-fold. …”
  19. 219
  20. 220